Cardiac Rehabilitation Program Effects on Functional Capacity and Quality of Life in Stable Chronic Heart Failure Patients: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202506534820803

Enrollment

Registered

2025-06-10

Start date

2024-01-03

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiology

Interventions

Rehabilitation

No intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria comprised an age range of 21 to 79 years, a diagnosis of chronic heart failure confirmed by cardiac echocardiography, stability under treatment, and the provision of signed informed consent

Exclusion criteria

Exclusion criteria: Patients lost to follow-up or those with poor adherence to cardiac rehabilitation sessions (fewer than 15 sessions within seven weeks) were excluded.

Design outcomes

Primary

Measure	Time frame
The primary outcome of this study was the VO2max, which represents the maximum amount of oxygen consumed per minute by the body, expressed in mL/min per kilogram of body weight	—

Secondary

Measure	Time frame
exercise tolerance;quality of life, measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ)	—

Countries

Cameroon

Contacts

Public ContactDoris Ekoume Bwemba

Faculty of Medicine and Biomedical Sciences University of Yaounde I

doris1111192@gmail.com+237695975886

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026